IKMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IKMED
Largest movements
- Receivables within one year +€26,514
up €26,514 (+588%), from €4,507 to €31,021
- Cash -€19,780
down €19,780 (-30.5%), from €64,848 to €45,068
mainly Receivables within one year (-€26,514) and Investment in fixed assets (net) (-€5,160)
- Tangible fixed assets +€3,967
new in 2025: €3,967
- Profit (loss) carried forward +€6,949
up €6,949 (+27.7%), from €25,100 to €32,049
- Other debts +€3,234
up €3,234 (+11.7%), from €27,662 to €30,896
- Accrued charges and deferred income +€1,691
new in 2025: €1,691
- Tax, wage and social debts -€1,163
down €1,163 (-12.6%), from €9,200 to €8,037
- Gross operating margin -€19,927
down €19,927 (-60.6%), from €32,861 to €12,934
- Taxes -€5,466
down €5,466 (-81.0%), from €6,752 to €1,286
- Financial charges +€1,703
up €1,703 (+970%), from €176 to €1,878
- Depreciation +€1,193
new in 2025: €1,193
- Other operating charges +€795
new in 2025: €795
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €69,355 | €80,624 | +€11,269 | +16.2% |
| Fixed assets | 21/28 | - | €3,967 | +€3,967 | |
| Tangible fixed assets | 22/27 | - | €3,967 | +€3,967 | |
| Plant, machinery and equipment | 23 | - | €3,967 | +€3,967 | |
| Current assets | 29/58 | €69,355 | €76,657 | +€7,302 | +10.5% |
| Amounts receivable within one year | 40/41 | €4,507 | €31,021 | +€26,514 | +588% |
| Trade receivables | 40 | €4,507 | €31,021 | +€26,514 | +588% |
| Cash at bank and in hand | 54/58 | €64,848 | €45,068 | -€19,780 | -30.5% |
| Deferred charges and accrued income | 490/1 | - | €568 | +€568 | |
| Total equity and liabilities | 10/49 | €69,355 | €80,624 | +€11,269 | +16.2% |
| Equity | 10/15 | €29,100 | €36,049 | +€6,949 | +23.9% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €25,100 | €32,049 | +€6,949 | +27.7% |
| Amounts payable | 17/49 | €40,254 | €44,575 | +€4,320 | +10.7% |
| Amounts payable within one year | 42/48 | €40,254 | €42,884 | +€2,630 | +6.5% |
| Trade debts | 44 | €3,392 | €3,950 | +€558 | +16.5% |
| Suppliers | 440/4 | €3,392 | €3,950 | +€558 | +16.5% |
| Taxes, remuneration and social security | 45 | €9,200 | €8,037 | -€1,163 | -12.6% |
| Taxes | 450/3 | €9,200 | €8,037 | -€1,163 | -12.6% |
| Other amounts payable | 47/48 | €27,662 | €30,896 | +€3,234 | +11.7% |
| Accrued charges and deferred income | 492/3 | - | €1,691 | +€1,691 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,193 | +€1,193 | |
| Other operating charges | 640/8 | - | €795 | +€795 | |
| Gross operating margin | 9900 | €32,861 | €12,934 | -€19,927 | -60.6% |
| Operating profit (loss) | 9901 | €32,861 | €10,946 | -€21,915 | -66.7% |
| Financial charges | 65/66B | €176 | €1,878 | +€1,703 | +970% |
| Recurring financial charges | 65 | €176 | €1,878 | +€1,703 | +970% |
| Profit (loss) for the period before taxes | 9903 | €32,685 | €9,067 | -€23,618 | -72.3% |
| Income taxes | 67/77 | €6,752 | €1,286 | -€5,466 | -81.0% |
| Profit (loss) for the period | 9904 | €25,933 | €7,782 | -€18,152 | -70.0% |
| Profit (loss) for the period to be appropriated | 9905 | €25,933 | €7,782 | -€18,152 | -70.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.